Peoples Financial Services Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3K | Hold |
50
| – | – | 0.01% | 206 |
|
|
2025
Q1 | $13.5K | Hold |
50
| – | – | 0.01% | 208 |
|
|
2024
Q4 | $11.8K | Hold |
50
| – | – | 0.01% | 214 |
|
|
2024
Q3 | $13.8K | Hold |
50
| – | – | 0.01% | 208 |
|
|
2024
Q2 | $12.2K | Hold |
50
| – | – | 0.01% | 211 |
|
|
2024
Q1 | $7.47K | Hold |
50
| – | – | ﹤0.01% | 221 |
|
|
2023
Q4 | $9.57K | Hold |
50
| – | – | ﹤0.01% | 219 |
|
|
2023
Q3 | $8.86K | Hold |
50
| – | – | ﹤0.01% | 223 |
|
|
2023
Q2 | $9.5K | Hold |
50
| – | – | ﹤0.01% | 223 |
|
|
2023
Q1 | $10K | Hold |
50
| – | – | ﹤0.01% | 221 |
|
|
2022
Q4 | $11.9K | Hold |
50
| – | – | 0.01% | 215 |
|
|
2022
Q3 | $10K | Hold |
50
| – | – | 0.01% | 223 |
|
|
2022
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 239 |
|
|
2022
Q1 | $8K | Hold |
50
| – | – | ﹤0.01% | 242 |
|
|
2021
Q4 | $8K | Hold |
50
| – | – | ﹤0.01% | 234 |
|
|
2021
Q3 | $9K | Hold |
50
| – | – | ﹤0.01% | 231 |
|
|
2021
Q2 | $8K | Hold |
50
| – | – | ﹤0.01% | 242 |
|
|
2021
Q1 | $7K | Hold |
50
| – | – | ﹤0.01% | 238 |
|
|
2020
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 243 |
|
|
2020
Q3 | $7K | Hold |
50
| – | – | ﹤0.01% | 220 |
|
|
2020
Q2 | $7K | Hold |
50
| – | – | ﹤0.01% | 225 |
|
|
2020
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 245 |
|
|
2019
Q4 | $6K | Hold |
50
| – | – | ﹤0.01% | 260 |
|
|
2019
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 290 |
|
|
2019
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 291 |
|
|
2019
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 273 |
|
|
2018
Q4 | $4K | Hold |
50
| – | – | ﹤0.01% | 280 |
|
|
2018
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 299 |
|
|
2018
Q2 | $5K | Buy |
+50
| New | +$5K | ﹤0.01% | 273 |
|